Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.

Milne RS, Silverman RA, Beck IA, Mckernan-Mullin J, Deng W, Sibley TR, Dross S, Kiarie JN, Sakr SR, Coombs RW, Chung MH, Frenkel LM.

AIDS. 2019 May 1;33(6):941-951. doi: 10.1097/QAD.0000000000002134.

PMID:
30946148
2.

Leveraging a Partnership to Disseminate and Implement What Works in Family Planning and Reproductive Health: The Implementing Best Practices (IBP) Initiative.

Thatte N, Cuzin-Kihl A, May AV, D'Adamo M, Addico G, Kiarie J, Askew I.

Glob Health Sci Pract. 2019 Mar 29;7(1):12-19. doi: 10.9745/GHSP-D-18-00236. Print 2019 Mar 22. No abstract available.

3.

Association between vaginal washing and detection of Lactobacillus by culture and quantitative PCR in HIV-seronegative Kenyan women: a cross-sectional analysis.

Lokken EM, Manguro GO, Abdallah A, Ngacha C, Shafi J, Kiarie J, Jaoko W, Srinivasan S, Fiedler TL, Munch MM, Fredricks DN, McClelland RS, Balkus JE.

Sex Transm Infect. 2019 Jan 29. pii: sextrans-2018-053769. doi: 10.1136/sextrans-2018-053769. [Epub ahead of print]

PMID:
30696752
4.

Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.

Milne RS, Silverman RA, Beck IA, Mckernan-Mullin J, Deng W, Sibley TR, Dross S, Kiarie JN, Sakr SR, Coombs RW, Chung MH, Frenkel LM.

AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002134. [Epub ahead of print]

PMID:
30664004
5.

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.

Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.

Contraception. 2019 Apr;99(4):199-204. doi: 10.1016/j.contraception.2018.12.001. Epub 2018 Dec 18.

6.

Postpartum family-planning barriers and catalysts in Burkina Faso and the Democratic Republic of Congo: a multiperspective study.

Tran NT, Yameogo WME, Gaffield ME, Langwana F, Kiarie J, Kulimba DM, Kouanda S.

Open Access J Contracept. 2018 Nov 9;9:63-74. doi: 10.2147/OAJC.S170150. eCollection 2018.

7.

A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection.

Månberg A, Bradley F, Qundos U, Guthrie BL, Birse K, Noël-Romas L, Lindskog C, Bosire R, Kiarie J, Farquhar C, Burgener AD, Nilsson P, Broliden K.

Mol Cell Proteomics. 2019 Mar;18(3):461-476. doi: 10.1074/mcp.RA118.000757. Epub 2018 Nov 30.

PMID:
30504243
8.

Higher prevalence of viral control in HIV-1-infected women in serodiscordant relationships.

Peebles K, McClelland RS, Overbaugh J, Richardson BA, Bosire R, Kiarie JN, Farquhar C, Guthrie BL.

PLoS One. 2018 Dec 5;13(12):e0208401. doi: 10.1371/journal.pone.0208401. eCollection 2018.

9.

WHO laboratory validation of Xpert® CT/NG and Xpert® TV on the GeneXpert system verifies high performances.

Jacobsson S, Boiko I, Golparian D, Blondeel K, Kiarie J, Toskin I, Peeling RW, Unemo M.

APMIS. 2018 Dec;126(12):907-912. doi: 10.1111/apm.12902.

10.

Behaviour change techniques in brief interventions to prevent HIV, STI and unintended pregnancies: A systematic review.

De Vasconcelos S, Toskin I, Cooper B, Chollier M, Stephenson R, Blondeel K, Troussier T, Kiarie J.

PLoS One. 2018 Sep 27;13(9):e0204088. doi: 10.1371/journal.pone.0204088. eCollection 2018.

11.

Birth spacing and informed family planning choices after childbirth in Burkina Faso and the Democratic Republic of Congo: Participatory action research to design and evaluate a decision-making tool for providers and their clients.

Tran NT, Yameogo WMM, Langwana F, Kouanda S, Thieba B, Mashinda D, Yodi R, Nyandwe Kyloka J, Millogo T, Coulibaly A, Zan S, Kini B, Ouedraogo B, Puludisi F, Cuzin-Kihl A, Reier S, Kiarie J, Gaffield ME.

Patient Educ Couns. 2018 Oct;101(10):1871-1875. doi: 10.1016/j.pec.2018.05.004. Epub 2018 May 2.

PMID:
30001823
12.

Participatory action research to identify a package of interventions to promote postpartum family planning in Burkina Faso and the Democratic Republic of Congo.

Tran NT, Yameogo WME, Langwana F, Gaffield ME, Seuc A, Cuzin-Kihl A, Kouanda S, Mashinda D, Thieba B, Yodi R, Nyandwe Kyloka J, Millogo T, Coulibaly A, Bolangala B, Zan S, Kini B, Ouedraogo B, Puludisi F, Landoulsi S, Kiarie J, Reier S.

BMC Womens Health. 2018 Jul 5;18(1):122. doi: 10.1186/s12905-018-0573-5.

13.

High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.

Liu AY, De Rosa SC, Guthrie BL, Choi RY, Kerubo-Bosire R, Richardson BA, Kiarie J, Farquhar C, Lohman-Payne B.

Immun Inflamm Dis. 2018 Sep;6(3):392-401. doi: 10.1002/iid3.231. Epub 2018 Jul 4.

14.

Effectiveness of a package of postpartum family planning interventions on the uptake of contraceptive methods until twelve months postpartum in Burkina Faso and the Democratic Republic of Congo: the YAM DAABO study protocol.

Tran NT, Gaffield ME, Seuc A, Landoulsi S, Yamaego WME, Cuzin-Kihl A, Kouanda S, Thieba B, Mashinda D, Yodi R, Kiarie J, Reier S.

BMC Health Serv Res. 2018 Jun 11;18(1):439. doi: 10.1186/s12913-018-3199-2.

15.

Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners.

Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, Ngure K, Kiarie J, Mugo N, Heffron R; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.

J Infect Dis. 2018 Jun 5;218(1):16-25. doi: 10.1093/infdis/jiy113.

PMID:
29514254
16.
17.

Advancing point of care diagnostics for the control and prevention of STIs: the way forward.

Toskin I, Blondeel K, Peeling RW, Deal C, Kiarie J.

Sex Transm Infect. 2017 Dec;93(S4):S81-S88. doi: 10.1136/sextrans-2016-053073.

18.

Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis.

Toskin I, Murtagh M, Peeling RW, Blondeel K, Cordero J, Kiarie J.

Sex Transm Infect. 2017 Dec;93(S4):S69-S80. doi: 10.1136/sextrans-2016-053071.

19.

Field evaluation of two point-of-care tests for syphilis among men who have sex with men, Verona, Italy.

Zorzi A, Cordioli M, Gios L, Del Bravo P, Toskin I, Peeling RW, Blondeel K, Cornaglia G, Kiarie J, Ballard R, Mirandola M.

Sex Transm Infect. 2017 Dec;93(S4):S51-S58. doi: 10.1136/sextrans-2016-053065.

20.

Point-of-care tests for STIs: the way forward.

Toskin I, Peeling RW, Mabey D, Holmes K, Ballard R, Kiarie J, Askew I.

Sex Transm Infect. 2017 Dec;93(S4):S1-S2. doi: 10.1136/sextrans-2016-053074. No abstract available.

21.

Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis.

Mugwanya KK, Baeten JM, Wyatt C, Mugo NR, Celum CL, Ronald A, Kiarie J, Katabira E, Heffron R; Partners PrEP Study and Partners Demonstration Project Teams.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):206-211. doi: 10.1097/QAI.0000000000001575.

22.
23.

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.

Silverman RA, Beck IA, Kiptinness C, Levine M, Milne R, McGrath CJ, Bii S, Richardson BA, John-Stewart G, Chohan B, Sakr SR, Kiarie JN, Frenkel LM, Chung MH.

J Infect Dis. 2017 Dec 19;216(12):1569-1578. doi: 10.1093/infdis/jix544.

24.
25.

Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.

Heffron R, McClelland RS, Balkus JE, Celum C, Cohen CR, Mugo N, Bukusi E, Donnell D, Lingappa J, Kiarie J, Fiedler T, Munch M, Fredricks DN, Baeten JM; Partners PrEP Study Team.

Lancet HIV. 2017 Oct;4(10):e449-e456. doi: 10.1016/S2352-3018(17)30110-8. Epub 2017 Jul 18.

26.
27.

Sexual Assault and HIV Postexposure Prophylaxis at an Urban African Hospital.

Muriuki EM, Kimani J, Machuki Z, Kiarie J, Roxby AC.

AIDS Patient Care STDS. 2017 Jun;31(6):255-260. doi: 10.1089/apc.2016.0274.

28.

Hormonal contraceptive methods and HIV: research gaps and programmatic priorities.

Riley HEM, Steyn PS, Achilles SL, Bass E, Gray AL, Polis CB, Kiarie JN.

Contraception. 2017 Aug;96(2):67-71. doi: 10.1016/j.contraception.2017.05.015. Epub 2017 Jun 7. No abstract available.

29.

Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya.

Njoroge A, Guthrie BL, Bosire R, Wener M, Kiarie J, Farquhar C.

Lipids Health Dis. 2017 Jun 9;16(1):110. doi: 10.1186/s12944-017-0503-9.

30.

Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.

Patel RC, Morroni C, Scarsi KK, Sripipatana T, Kiarie J, Cohen CR.

J Int AIDS Soc. 2017 May 11;20(1):21396. doi: 10.7448/IAS.20.1.21396. Review.

31.

Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium.

Lokken EM, Balkus JE, Kiarie J, Hughes JP, Jaoko W, Totten PA, McClelland RS, Manhart LE.

Am J Epidemiol. 2017 Jul 15;186(2):194-201. doi: 10.1093/aje/kwx043.

32.

Supporting people living with HIV in serodiscordant partnerships to attempt a desired pregnancy by integrating sexual and reproductive health and HIV interventions.

Narasimhan M, Celum C, Askew I, Kiarie J, van der Poel S.

J Int AIDS Soc. 2017 Mar 8;20(Suppl 1):21829. doi: 10.7448/IAS.20.2.21829. No abstract available.

33.

Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol.

Buttolph J, Inwani I, Agot K, Cleland CM, Cherutich P, Kiarie JN, Osoti A, Celum CL, Baeten JM, Nduati R, Kinuthia J, Hallett TB, Alsallaq R, Kurth AE.

JMIR Res Protoc. 2017 Mar 8;6(3):e22. doi: 10.2196/resprot.5833.

34.
36.

Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.

Birse KD, Romas LM, Guthrie BL, Nilsson P, Bosire R, Kiarie J, Farquhar C, Broliden K, Burgener AD.

J Infect Dis. 2017 Feb 15;215(4):590-598. doi: 10.1093/infdis/jiw590.

37.

Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels.

Slyker JA, Richardson B, Chung MH, Atkinson C, Ásbjörnsdóttir KH, Lehman DA, Boeckh M, Emery V, Kiarie J, John-Stewart G.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):332-338. doi: 10.1089/AID.2016.0121. Epub 2016 Dec 6.

38.

An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.

Polis CB, Curtis KM, Hannaford PC, Phillips SJ, Chipato T, Kiarie JN, Westreich DJ, Steyn PS.

AIDS. 2016 Nov 13;30(17):2665-2683. Review.

39.

Treatment outcomes of drug-resistant tuberculosis patients in Kenya.

Mibei DJ, Kiarie JW, Wairia A, Kamene M, Okumu ME.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1477-1482.

PMID:
27776588
40.

The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta-Analysis.

Zemouri C, Wi TE, Kiarie J, Seuc A, Mogasale V, Latif A, Broutet N.

PLoS One. 2016 Oct 5;11(10):e0163365. doi: 10.1371/journal.pone.0163365. eCollection 2016. Review.

41.

Use of the World Health Organization's Medical Eligibility Criteria for Contraceptive Use Guidance in sub-Saharan African Countries: A Cross-Sectional Study.

Chen MJ, Gaffield ME, Kiarie J.

Glob Health Sci Pract. 2016 Sep 29;4(3):506-10. doi: 10.9745/GHSP-D-16-00216. Print 2016 Sep 28.

42.

Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies.

Festin MPR, Peregoudov A, Seuc A, Kiarie J, Temmerman M.

Contraception. 2017 Jan;95(1):50-54. doi: 10.1016/j.contraception.2016.08.001. Epub 2016 Aug 12.

43.

The amount of penicillin needed to prevent mother-to-child transmission of syphilis.

Taylor MM, Zhang X, Nurse-Findlay S, Hedman L, Kiarie J.

Bull World Health Organ. 2016 Aug 1;94(8):559-559A. doi: 10.2471/BLT.16.173310. No abstract available.

44.

WHO medical eligibility criteria update.

Gaffield ML, Kiarie J.

Contraception. 2016 Sep;94(3):193-4. doi: 10.1016/j.contraception.2016.07.001. No abstract available.

45.

Participatory approaches involving community and healthcare providers in family planning/contraceptive information and service provision: a scoping review.

Steyn PS, Cordero JP, Gichangi P, Smit JA, Nkole T, Kiarie J, Temmerman M.

Reprod Health. 2016 Jul 22;13(1):88. doi: 10.1186/s12978-016-0198-9. Review.

46.

Estimating Benzathine Penicillin Need for the Treatment of Pregnant Women Diagnosed with Syphilis during Antenatal Care in High-Morbidity Countries.

Taylor MM, Nurse-Findlay S, Zhang X, Hedman L, Kamb ML, Broutet N, Kiarie J.

PLoS One. 2016 Jul 19;11(7):e0159483. doi: 10.1371/journal.pone.0159483. eCollection 2016.

47.

Moving towards the goals of FP2020 - classifying contraceptives.

Festin MP, Kiarie J, Solo J, Spieler J, Malarcher S, Van Look PF, Temmerman M.

Contraception. 2016 Oct;94(4):289-94. doi: 10.1016/j.contraception.2016.05.015. Epub 2016 Jun 7.

48.

Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.

Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, Tappero JW, Kiarie J, Ronald A, Mujugira A, Tumwesigye E, Were E, Irungu E, Baeten JM; Partners PrEP Study Team.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):313-322.

49.

Male Partner Participation in Antenatal Clinic Services is Associated With Improved HIV-Free Survival Among Infants in Nairobi, Kenya: A Prospective Cohort Study.

Aluisio AR, Bosire R, Bourke B, Gatuguta A, Kiarie JN, Nduati R, John-Stewart G, Farquhar C.

J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):169-76. doi: 10.1097/QAI.0000000000001038.

50.

The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.

Gottlieb SL, Deal CD, Giersing B, Rees H, Bolan G, Johnston C, Timms P, Gray-Owen SD, Jerse AE, Cameron CE, Moorthy VS, Kiarie J, Broutet N.

Vaccine. 2016 Jun 3;34(26):2939-2947. doi: 10.1016/j.vaccine.2016.03.111. Epub 2016 Apr 19. Review.

Supplemental Content

Loading ...
Support Center